You are here

application areas

application areas

EEG and cognitive evoked potentials have a role in the evaluation of certain psychiatric patients. Cognitive tests can be in daily routine to discriminate between psychiatric and neurological diseases. Topographical maps of the spectral power of EEG and the event-related brain responses provide information that helps differentiating psychiatric from neurological cases.

  • Attention deficit (ADHD)
    Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurological brain disorder that manifests itself as a persistent pattern of inattention and/or hyperactivity/impulsivity. It begins in childhood and affects 3 to 5% of the school age population. Although the symptoms of ADHD are clear in some cases, it is extremely difficult to assess the severity of ADHD. Early diagnosis of ADHD is important and with Cognitrace, ANT offers a powerfull tool for mental-health professionals.
     
  • Anxiety disorders
    Generalized anxiety disorder, panic disorder, post-traumatic stress disorder, obsessive-compulsive disorder (OCD), phobias; millions of people worldwide are affected by anxiety disorders. Neurophysiological tests as provided by Cognitrace can help in diagnosing the severity and type of anxiety.
     
  • Alzheimer & Dementia
    Alzheimer's disease (AD), a neurodegenerative disorder, is the most common cause of dementia and characterized clinically by progressive intellectual deterioration together with declining activities of daily living as neuropsychiatric symptoms or behavioral changes. Diagnosis is made primarily by clinical observation and tests related to memory and intellectual functioning over a series of weeks or months. However, Cognitrace offers a series of tools that may allow the health-professional to assess faster the severity of Alzheimer and differentiate between dementia and depression.
     
  • Head injury
    Head injury is a trauma to the head, that may or may not include injury to the brain. Common symptoms of traumatic brain injury are loss of consciousness, confusion, drowsiness, double vision, seizures and headache. Because brain injuries can be life threatening, even people with apparently slight injuries, with no noticeable signs or complaints, require close observation.
     
  • Schizophrenia
    Schizophrenia is a chronic, severe, and disabling brain disease. Approximately 1% of the population develops schizophrenia during lifetime. For diagnosing schizophrenia it is important to rule out other illnesses, as sometimes people suffer severe mental symptoms or even psychosis due to undetected underlying medical conditions. The Cognitrace system offers a variety of cognitive tests for this particular disease.
     
  • Depression
    Clinical depression affects about 16% of the population on at least one occasion in their lives. Various types of depression are recognized by clinicians, for instance: major depression, dysthymia and bipolar disorder. Because of this profound and often overwhelmingly negative outlook of patients, it is imperative that the depressed individual seek professional help. With Cognitrace ANT offers professionals objective data that helps to differentiate between psychiatric and neurological disorders.
     
  • Psychoses
    Psychosis is a generic psychiatric term for mental states in which the components of rational thought and perception are severely impaired. Although it is not exclusively linked to any particular psychological or physical state, it is particularly associated with schizophrenia, bipolar disorder (manic depression) and severe clinical depression. Cognitrace offers health professionals tools for differential diagnosis within a relatively small amount of time.
     
  • Dyslexia
    Dyslexia is a neurological disorder characterised by distorted and incorrect writing, difficulty in speech production, etc. It has been shown that early diagnosis and treatment can almost completely eliminate the symptoms of dyslexia. The symtoms of dyslexia are quite similar to those of ADD and often clinicians diagnose students with attention deficit disorder rather than dyslexia. Hence it is extremely important to have objective measures in diagnosing and differentiating between disorders.
© Copyright 1999 - 2016 ANT Neuro | www.ant-neuro.com | Terms of Use | Privacy Statement | Contact | USA Customers